Translate
Hangzhou Tigermed Consulting
About
Hangzhou Tigermed Consulting (SHE:300347) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 30 2026
Tigermed Announces 2025 Annual Results
Nov 6 2025
Tigermed Selected as "2025 Forbes China Go-International Flagship Brands" Top 30
Aug 19 2025
Tigermed Receives MSCI ESG AAA Rating
Jul 29 2025
Tigermed Completes Acquisition of Japanese CRO Micron
Mar 27 2025
Tigermed Reports Full Year 2024 Results
Financials
Revenue
CN¥6.83 B
Market Cap
CN¥47.61 B
P/E Ratio
53.17
EPS
1.04
Dividend Yield
0.22%